Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation
geralt / Pixabay

Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation

According to a story from prnewswire.com, the biopharmaceutical company Aridis Pharmaceuticals, Inc. has recently announced that the US Food and Drug Administration (FDA) has awarded Orphan Drug designation to the…

Continue Reading Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation

The Future Looks Brighter for Premature Babies Thanks to Stem Cell Research and Tissue Engineered Intestines

  Dr. Tracy Grikscheit is a leading surgeon in the field of tissue engineering. Dr. Grikscheit, together with her colleagues at Children’s Hospital Los Angeles, co-authored an article for the…

Continue Reading The Future Looks Brighter for Premature Babies Thanks to Stem Cell Research and Tissue Engineered Intestines

New Clinical Trial Application for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Submitted in Sweden

Dicerna Pharmaceuticals has just announced that they have submitted a Clinical Trial Authorization application for their investigational therapy DCR-A1AT. This application has been submitted to the Swedish Medical Products Agency…

Continue Reading New Clinical Trial Application for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Submitted in Sweden
Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them
https://pixabay.com/en/money-coins-donate-moneybox-cash-230265/

Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them

According to a publication from the Basingstoke Gazette, a Basingstoke family is raising money for the children's hospice center that supported them through the loss of a child. Jessica and…

Continue Reading Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them
Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment
mwooten / Pixabay

Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment

According to a story from BioPortfolio, the biopharmaceutical company X4 Pharmaceuticals, Inc. has recently initiated a phase 3 clinical trial that is testing its current lead product candidate mavorixafor. This…

Continue Reading Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment
Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
source: pixabay.com

Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial

According to a story from BioPortfolio, the drug company Pfizer has recently presented data from its phase 1b clinical trial that tested the company's experimental gene therapy PF-06939926, which is…

Continue Reading Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas
lisichik / Pixabay

Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas

According to a press release from the Texas Biomedical Research Institute (Texas Biomed), researchers from the Institute have identified another new genetic mutation that they believe can cause rare congenital…

Continue Reading Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas

Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment

Inflammatory Bowel Diseases Inflammatory bowel diseases (IBD) is the overarching term for both ulcerative colitis and Crohn's disease. In Canada, there are around 270,000 individuals living with the one of…

Continue Reading Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment
Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids
https://pixabay.com/en/technology-robot-human-hand-2025795/

Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids

According to a press release from the Children's National Health System (a children's hospital in Washington, D.C.), two scientists from the Institution have been selected to receive federal funding grants…

Continue Reading Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids